ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · IEX Real-Time Price · USD
3.220
+0.190 (6.27%)
At close: Jul 26, 2024, 4:00 PM
3.280
+0.060 (1.86%)
After-hours: Jul 26, 2024, 5:15 PM EDT

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $61.43 million as of July 26, 2024. Its market cap has decreased by -49.52% in one year.

Market Cap
61.43M
Enterprise Value
82.98M
1-Year Change
-49.52%
Ranking
Category
Stock Price
$3.22

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $61.43M, a decrease of -33.23%. That is a compound annual growth rate of -1.56%.

History

DateMarket Cap% Change
Jul 25, 202457.80M-29.17%
Dec 29, 202381.60M-47.96%
Dec 30, 2022156.80M41.01%
Dec 31, 2021111.20M4.41%
Dec 31, 2020106.50M367.11%
Dec 31, 201922.80M-37.36%
Dec 31, 201836.40M34.81%
Dec 29, 201727.00M-21.05%
Dec 30, 201634.20M33.59%
Dec 31, 201525.60M13.27%
Dec 31, 201422.60M-11.72%
Dec 31, 201325.60M26.73%
Dec 31, 201220.20M19.53%
Dec 30, 201116.90M-3.98%
Dec 31, 201017.60M-30.98%
Dec 31, 200925.50M-50.58%
Dec 31, 200851.60M-15.69%
Dec 31, 200761.20M-15.24%
Dec 29, 200672.20M-55.24%
Dec 30, 2005161.30M64.42%
Dec 31, 200498.10M-19.85%
Dec 31, 2003122.40M94.29%
Dec 31, 200263.00M156.10%
Dec 31, 200124.60M179.55%
Dec 29, 20008.80M-46.67%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Vor Biopharma 66.26M
Intensity Therapeutics 65.80M
Celularity 65.57M
Pro-Dex 65.24M
MediciNova 63.27M
Entera Bio 62.19M
Cryo-Cell International 61.27M
VolitionRx 60.54M
Market Cap Rankings